An innovative and non-invasive method in early detection and follow-up for cancer
Erganeo and METHYS Dx announce news of an exclusive licensing agreement for the use of diagnostic biomarkers via liquid biopsy.
The French government has allocated €275 million to 17 “maturation – prematuration” consortia including 9 in which Erganeo participates
Sylvie Retailleau, French Minister of Higher Education and Research, unveiled the list of 17 winners of the France 2030 call for "maturation - prematuration" projects, including 9 consortia with Erganeo.
The Sci-Ty project, “Innovation for the Cities and Mobilities of Tomorrow”, co-directed by the Gustave Eiffel University and the SATT Erganeo, winner of the France 2030 call for pre-maturation-maturation projects
Sylvie Retailleau, Minister for Higher Education and Research, and her counterpart Roland Lescure, Minister for Industry, unveiled the names of the winners of the France 2030 "maturation-pre-maturation" AAP.
Gene and cell therapy by suicide gene to treat liver cancer
An exclusive license was signed on 10 November, 2022, between Erganeo and the start-up Persea, for development of a new treatment for liver cancer.
An antibody for new serological tests
An antibody enabling the development of new medical tests for the diagnosis of SARS-CoV-2 antibodies and other disease related to serological antibodies.